Clorox (CLX) 2025 annual meeting: directors elected, EY ratified
Rhea-AI Filing Summary
The Clorox Company reported results of its virtual annual shareholder meeting held on November 19, 2025. Shareholders elected all company nominees to the board of directors, confirming the full slate of directors listed in the meeting materials.
Investors also approved, on an advisory basis, the compensation of Clorox’s named executive officers, indicating support for the company’s executive pay program. In addition, shareholders ratified the selection of Ernst & Young LLP as Clorox’s independent registered public accounting firm for the fiscal year ending June 30, 2026, allowing the firm to continue in its audit role.
Positive
- None.
Negative
- None.
8-K Event Classification
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of | (Commission File Number) | (I.R.S. Employer |
| incorporation) | Identification No.) |
(Address of principal executive offices) (Zip code)
(
(Registrant's telephone number, including area code)
Not applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communications pursuant to Rule 425 Under the Securities Act (17 CFR 230.425) | |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) | |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) | |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) |
Name of each exchange on which registered |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.07 Submission of Matters to a Vote of Security Holders.
| (a) | On November 19, 2025, The Clorox Company (the “Company”) held its virtual annual meeting of shareholders. |
| (b) | The shareholders (1) elected all of the Company’s nominees for director, (2) approved the compensation of the Company’s named executive officers on an advisory basis, and (3) ratified the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2026. |
The final voting results on each of the matters submitted to a vote are as follows:
| 1. | Election of Directors: |
| Number of Votes | ||||||||
| For | Against | Abstain | Broker Non-Votes | |||||
| Gina Boswell | 87,241,439 | 911,643 | 304,320 | 16,748,497 | ||||
| Stephen B. Bratspies | 87,311,360 | 828,040 | 318,002 | 16,748,497 | ||||
| Pierre R. Breber | 86,288,908 | 1,855,117 | 313,378 | 16,748,497 | ||||
| Julia Denman | 87,349,899 | 806,877 | 300,626 | 16,748,497 | ||||
| Esther Lee | 84,749,929 | 3,372,071 | 335,403 | 16,748,497 | ||||
| A.D. David Mackay | 87,066,608 | 1,080,570 | 310,224 | 16,748,497 | ||||
| Stephanie Plaines | 86,840,639 | 1,222,967 | 393,796 | 16,748,497 | ||||
| Linda Rendle | 81,216,339 | 6,634,729 | 606,334 | 16,748,497 | ||||
| Matthew J. Shattock | 87,292,871 | 850,101 | 314,430 | 16,748,497 | ||||
| Russell J. Weiner | 85,462,554 | 2,668,550 | 326,299 | 16,748,497 | ||||
| Christopher J. Williams | 86,560,378 | 1,529,347 | 367,677 | 16,748,497 | ||||
| 2. | Advisory Vote on the Approval of Named Executive Officers Compensation: |
| Number of Votes | ||||||
| For | Against | Abstain | Broker Non-Votes | |||
| 79,985,792 | 7,577,339 | 894,271 | 16,748,497 | |||
| 3. | Ratification of the selection of Ernst & Young LLP as the Company’s independent auditor for 2026. |
| Number of Votes | ||||||
| For | Against | Abstain | Broker Non-Votes | |||
| 99,330,452 | 5,516,058 | 359,389 | 0 | |||
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
See the Exhibit Index below.
EXHIBIT INDEX
| Exhibit | Description | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| THE CLOROX COMPANY | |||
| Date: | November 20, 2025 | By: | /s/ Angela Hilt |
| Angela Hilt | |||
| Executive Vice President - Chief Legal and External Affairs Officer and Corporate Secretary | |||